Microbiome Stock

I believe that every chronic disease known to man is caused, at least in large part, to imbalances in the gut microbiome. This includes autoimmune disease, autism, mental illness, age-related conditions, etc. Manipulating the microbiome can help cure/treat cancer too. Research is in its infancy but I have been looking into trying to get in early on some stock in this space. There have already been 2 drugs approved for C. Diff but this is just the tip of the iceberg. SERES therapeutics just failed with their drug trial for ulcerative colitis. Their drug had a consortium of several bacteria in it, probably in spore form? A company on the Paris exchange called MAAT pharma has the next microbiome drug to be approved, for Graft-Vs-Host disease, which is expected to be approved in Europe in the second quarter of this year. I like this company because it co-cultures the microorganisms and transfers an ecosystem as opposed to just the bacterial strains that they are guessing at (at least this is what it seems like from my reading as a lay person). The company also has other microbiome drugs in the pipeline, including for cancer, and their stuff is at slightly later stages than their competitors. The company also has a target price of 3 times what it is now. Was looking for opinions on the company... I personally have a lot of faith in this stuff but I do not exactly have a good track record when it comes to investing lol Thanks for reading